Trial intelligence / Profile preview

Vesanoid and Ipilimumab in Advanced Melanoma

NCT02403778Phase 2Completed

Sponsor
University of Colorado Denver
Start
Dec 2015
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tretinoin in melanoma, sponsored by University of Colorado Denver. Started Dec 2015; status: completed.

02

Drugs

tretinoin
03

Conditions

melanoma

Beyond the preview

Go deeper on NCT02403778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02403778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call